Receptor Processing Sample Clauses

Receptor Processing. N-terminal fragments of GPR37L1 have been identified in human cerebral spinal fluid (CSF), suggesting the processing of GPR37L1 may be biologically relevant (Xxxxx et al. 2001; Zhao et al. 2010). Interestingly, while GPR37 and GPR37L1 have predicted molecular weights of 67 and 53kDa respectively, the predominant form of both receptors detected following sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) is roughly 20kDa below their predicted sizes (Imai et al. 2001; Rezgaoui et al. 2006; Marazziti et al. 2007; Omura et al. 2008; Xxxxxxx, Tuusa, and Petaja-Repo 2016; Xxxxxxx et al. 2016). Immunodetection with C-terminal antibodies suggests the main form of the receptor is N-terminally cleaved. Endothelin B (ETB), the most closely related neighbor to GPR37 and GPR37L1 is also known to undergo N-terminal cleavage. Studies with N-terminally truncated forms of ETB show reduced surface expression, suggesting receptor processing may regulate surface expression (Xxxxxxxxxxxx et al. 2002). Similar studies with an N-terminally truncated form of GPR37 indicate truncated versions of the receptor display increased surface expression (Xxxxxx et al. 2009; Xxxxxxx, Tuusa, and Petaja-Repo 2016). Expression of GPR37 modified to contain dual epitope tags at the N and C termini, clearly demonstrate the existence of several differentially sized versions of the receptor (Xxxxxxx, Tuusa, and Petaja-Repo 2016). The most abundantly expressed form was detected at 53kDa and contained only the CT epitope tag, suggesting an N-terminally truncated form of the receptor. Pulse-chase labeling of HEK cells stably-transfected with GPR37, reveals that cleavage of the receptor occurs after processing of receptor N-glycans in the Golgi (Xxxxxxx, Tuusa, and Petaja-Repo 2016). Co-localization with endocytic markers indicate that GPR37 is cleaved only after it leaves the trans-Golgi network. Additionally, broad-range metalloproteinase inhibitors, GM6001, TAPI-1 and marimastat prevent GPR37 cleavage and increase the amount of full-length receptor at the cell surface (Xxxxxxx, Tuusa, and Petaja-Repo 2016). The functional role of GPR37 cleavage has yet to be investigated. Xxxxxxx and colleagues (Xxxxxxx et al. 2016) set out to determine the functional significance of GPR37L1 N-terminal cleavage. In contrast to GPR37, removal of the N-terminus of GPR37L1 reduces total and surface expression. Furthermore, truncation of the NT completely abolished GPR37L1’s constitutive signaling to C...
AutoNDA by SimpleDocs

Related to Receptor Processing

  • Subprocessing 1. The data importer shall not subcontract any of its processing operations performed on behalf of the data exporter under the Clauses without the prior written consent of the data exporter. Where the data importer subcontracts its obligations under the Clauses, with the consent of the data exporter, it shall do so only by way of a written agreement with the subprocessor which imposes the same obligations on the subprocessor as are imposed on the data importer under the Clauses. Where the subprocessor fails to fulfil its data protection obligations under such written agreement the data importer shall remain fully liable to the data exporter for the performance of the subprocessor's obligations under such agreement.

  • Order Processing Any order by you for the purchase of shares of the respective Funds through us shall be accepted at the time when it is received by us (or any clearing house agency that we may designate from time to time), and at the offering and sale price next determined, unless rejected by us or the respective Funds. In addition to the right to reject any order, the Funds have reserved the right to withhold shares from sale temporarily or permanently. We will not accept any order from you that is placed on a conditional basis or subject to any delay or contingency prior to execution. The procedures relating to the handling of orders shall be subject to instructions that we shall forward from time to time to all members of the Selling Group. The shares purchased will be issued by the respective Funds only against receipt of the purchase price, in collected New York or Los Angeles Clearing House funds subject to deduction of all concessions on such sale (reallowance of any concessions to which you are entitled on purchases at net asset value will be paid through our direct purchase concession system). If payment for the shares purchased is not received within three days after the date of confirmation the sale may be cancelled forthwith, by us or by the respective Funds, without any responsibility or liability on our part or on the part of the Funds, and we and/or the respective Funds may hold you responsible for any loss, expense, liability or damage, including loss of profit suffered by us and/or the respective Funds, resulting from your delay or failure to make payment as aforesaid.

  • Sub-processing 1. The data importer shall not subcontract any of its processing operations performed on behalf of the data exporter under the Clauses without the prior written consent of the data exporter. Where the data importer subcontracts its obligations under the Clauses, with the consent of the data exporter, it shall do so only by way of a written agreement with the sub-processor which imposes the same obligations on the sub-processor as are imposed on the data importer under the Clauses. Where the sub-processor fails to fulfil its data protection obligations under such written agreement the data importer shall remain fully liable to the data exporter for the performance of the sub-processor’s obligations under such agreement.

  • Scope of Processing The subject-matter of Processing of Personal Data by Okta is the performance of the Service pursuant to the Agreement. The duration of the Processing, the nature and purpose of the Processing, the types of Personal Data and categories of Data Subjects Processed under this DPA are further specified in Appendix 1 to this DPA.

  • Details of Processing 3.1. For details of how personal data is processed under this Agreement, please register to see our "GDPR Portal" at xxxxx://xxxxxx- xxxxxxx.xxxxx.xxx/Xxxxxxx/x/xxxx-xxx. You may also request a copy of the Product Fact Sheet from Your Access Account Manager.

  • Signaling protocol The Parties will interconnect their networks using SS7 signaling where Technically Feasible and available as defined in GR 905 Telcordia Standards including ISDN User Part (ISUP) for trunk signaling and TCAP for CCS-based features in the Interconnection of their networks. All Network Operations Forum (NOF) adopted standards shall be adhered to. Where available, CenturyLink signaling services to link its Signaling Transfer Points (STPs) for CLEC switches which connect to CenturyLink’s STPs via “A” links or for CLEC’s STPs to connect to CenturyLink’s STPs via “D” links which are dedicated to the transport of signaling for local Interconnection, may be ordered from the CenturyLink Tariff.

  • Specific Order Processes and Requirements 1. Distributor will order Software from SAP using and filling out completely such forms and minimum order requirements as SAP may prescribe from time to time and must comply with any then-current order process for the specific Software product. Where applicable, Distributor agrees to use the electronic means provided by SAP for placing orders.

  • Reactivation To reactivate suspended Service, you must bring your account current through the month of reactivation by making payment in full of any outstanding balance, fees and other applicable charges. In addition, we may require a deposit before reactivating your Service. The amount of the deposit will not exceed one year of monthly fees. Any amounts deposited by you will appear on your statement as a credit, and service charges and other fees will be invoiced as described above. If you fail to pay any amount on a subsequent xxxx, the unpaid amount will be deducted each billing cycle from the credit amount. Credit amounts will not earn or accrue interest.

  • Signaling Each Party will provide the other Party with access to its databases and associated signaling necessary for the routing and completion of the other Party’s traffic in accordance with the provisions contained in the Unbundled Network Element Attachment or applicable access tariff.

  • Hepatitis B Vaccine Where the Hospital identifies high risk areas where employees are exposed to Hepatitis B, the Hospital will provide, at no cost to the employees, a Hepatitis B vaccine.

Time is Money Join Law Insider Premium to draft better contracts faster.